Weekly Refresh: Clearcover’s New Execs, Chicago VCs Are Optimistic, and More

by Anna Holmquist
August 31, 2020
Photo: Shutterstock

Abbott’s coronavirus test received FDA approval. Its rapid antigen test, called BinaxNOW, can potentially detect infection in just 15 minutes. It costs just $5 per test. [Built In Chicago]

Chicago VCs remain optimistic. Despite the COVID-19 pandemic, the tech leaders surveyed think the virus and response to it actually has the power to re-accelerate the startup community. [TechCrunch]

Azul 3D raised $12.5M. The company owns proprietary 3D printing technology and with the funds will launch its first commercial printers. This latest round brought its total funding raised to over $20 million. [Built In Chicago]

mHUB closed first round of $15M venture fund. mHUB Product Impact Fund I plans to invest in seed and early stage hardtech companies in the United States. Its goal is to raise a total of $15 million. Sam Zell is an investor in the fund. [Press Release]

Clearcover hired two new executives. The company offers car insurance powered by technology. It brought on Norman Smagley as chief financial officer and Vandana Venkat as chief insurance officer. [PRWeb]

Chicago startup guides

Best Companies to Work for in Chicago
Coolest Offices in Chicago Tech
Best Perks at Chicago Tech Companies
Women in Chicago Tech